Astrana Health
ASTH
37.14
+0.14
+0.38%
Astrana Health
US · ASTH
#2768 by market cap
Listed 1970
37.14
+0.14
+0.38%
Live - 5344 symbols - heartbeat 27s ago
· 2026-10-07 19:54
After-hours
37.14
0.00%
- Market cap
- 2.07B
- P/E (TTM)i
- 45.29
- P/Bi
- 2.49
- EPSi
- 0.46
- Div yieldi
- 0.00%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on ASTH?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
52.00 +40.0%
Price target rangecurrent 37.14
Low41.00
Avg52.00
High65.00
Buy 89%
Hold 11%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | Freedom Capital Markets | -- | BUY | 50.00 |
| 2026-09-29 | Truist Financial | -- | BUY | -- |
| 2026-09-15 | Oppenheimer | -- | BUY | 53.00 |
| 2026-08-28 | Barclays | -- | BUY | 53.00 |
| 2026-08-19 | Freedom Capital Markets | -- | BUY | 50.00 |
| 2026-08-11 | Truist Financial | -- | BUY | 55.00 |
| 2026-08-10 | Truist Financial | -- | BUY | 55.00 |
| 2026-08-09 | BTIG | -- | BUY | 65.00 |
| 2026-08-07 | KeyBanc | -- | HOLD | -- |
| 2026-08-07 | Truist Financial | -- | BUY | -- |
| 2026-08-07 | Needham | -- | BUY | 41.00 |
| 2026-08-07 | Barclays | -- | BUY | 53.00 |
| 2026-08-06 | William Blair | -- | BUY | -- |
| 2026-07-16 | BTIG | -- | BUY | 65.00 |
| 2026-07-15 | BTIG | -- | BUY | 65.00 |
| 2026-07-14 | TD Cowen | -- | BUY | 50.00 |
| 2026-07-14 | BTIG | -- | BUY | 65.00 |
| 2026-07-13 | TD Cowen | -- | BUY | 50.00 |
| 2026-07-02 | Truist Financial | -- | BUY | -- |
| 2026-06-30 | Jefferies | -- | BUY | 53.00 |
| 2026-06-02 | BTIG | -- | BUY | 50.00 |
| 2026-06-01 | Truist Financial | -- | BUY | -- |
| 2026-05-26 | Barclays | -- | BUY | 50.00 |
| 2026-05-18 | Truist Financial | -- | BUY | 47.00 |
| 2026-05-14 | Truist Financial | -- | BUY | 47.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Barclays moved from Hold to Buy on 2026-05-26.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-05-26 | Barclays | HOLD → BUY | 50.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±13.74% | +4.78% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±8.06% | +8.92% (beat) |
| 2025/Q4 | 2026-03-02 | -- | ±13.79% | +29.46% (beat) |
| 2025/Q3 | 2025-11-06 | After close | ±13.79% | -23.46% (beat) |
| 2025/Q2 | 2025-08-07 | After close | ±20.19% | +30.85% (beat) |
| 2025/Q1 | 2025-05-08 | After close | ±13.24% | -11.14% (in line) |
| 2024/Q4 | 2025-02-27 | After close | ±23.93% | -26.82% (beat) |
| 2024/Q3 | 2024-11-07 | After close | ±9.72% | -20.51% (beat) |
| 2024/Q2 | 2024-08-07 | After close | ±22.27% | +1.06% (in line) |
| 2024/Q1 | 2024-05-07 | After close | -- | +0.42% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.